Central Bank & Trust Co. Has $5.46 Million Stock Position in Stryker Corporation $SYK

Central Bank & Trust Co. boosted its position in shares of Stryker Corporation (NYSE:SYK) by 23.8% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 15,521 shares of the medical technology company’s stock after purchasing an additional 2,980 shares during the period. Central Bank & Trust Co.’s holdings in Stryker were worth $5,455,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in SYK. Appleton Partners Inc. MA boosted its holdings in shares of Stryker by 0.8% in the 4th quarter. Appleton Partners Inc. MA now owns 30,507 shares of the medical technology company’s stock worth $10,722,000 after acquiring an additional 253 shares in the last quarter. Diversified Trust Co. increased its holdings in Stryker by 58.3% during the 4th quarter. Diversified Trust Co. now owns 19,704 shares of the medical technology company’s stock valued at $6,925,000 after purchasing an additional 7,259 shares in the last quarter. Carr Financial Group Corp increased its holdings in Stryker by 8.2% during the 4th quarter. Carr Financial Group Corp now owns 739 shares of the medical technology company’s stock valued at $260,000 after purchasing an additional 56 shares in the last quarter. Dynamic Advisor Solutions LLC raised its position in Stryker by 4.2% in the 4th quarter. Dynamic Advisor Solutions LLC now owns 7,088 shares of the medical technology company’s stock valued at $2,491,000 after purchasing an additional 287 shares during the last quarter. Finally, Sound View Wealth Advisors Group LLC boosted its stake in Stryker by 4.5% in the fourth quarter. Sound View Wealth Advisors Group LLC now owns 9,803 shares of the medical technology company’s stock worth $3,445,000 after purchasing an additional 419 shares in the last quarter. 77.09% of the stock is currently owned by institutional investors and hedge funds.

More Stryker News

Here are the key news stories impacting Stryker this week:

• Positive Sentiment: Stryker reports containment of the cybersecurity incident and progress in system restoration; operations are stabilizing, which reduces near-term disruption risk. Stryker reports progress in restoration efforts after cyberattack, operations continue to stabilize
• Positive Sentiment: Market reaction showed short-term relief: several outlets noted shares briefly rose after the company said the incident was contained, reflecting lowered immediate operational risk. Stryker shares climb after company says cybersecurity incident contained
• Neutral Sentiment: Stryker announced its 2026 Annual Meeting of Shareholders — routine corporate governance item with limited direct market impact. Stryker announces Annual Meeting of Shareholders
• Neutral Sentiment: Analyst / sector comparisons (Envista, Intuitive Surgical) discuss valuation and growth positioning versus Stryker; useful for longer-term allocation decisions but not the day’s price driver. NVST or SYK: Which Is the Better Value Stock Right Now? Intuitive Surgical vs. Stryker: Which Surgical Tech Stock Leads?
• Negative Sentiment: Coverage emphasizes that attackers (including state-linked criminal groups) are mounting disruptive, multifaceted campaigns that can extract leverage beyond data theft — raising the risk of longer recovery costs, regulatory scrutiny, and reputation/competitive impacts. Stryker Cyberattack Highlights Criminal Focus on Enterprise Systems
• Negative Sentiment: Company had disclosed the incident to the SEC earlier in March; lingering uncertainty around remediation costs, potential supply/servicing disruption, and any customer impact keeps downside risk for the stock until full restoration and forensic results are confirmed. Stryker Addresses and Contains Recent Cybersecurity Incident

Insider Activity

In other news, Director Ronda E. Stryker sold 250,000 shares of the firm’s stock in a transaction dated Wednesday, February 4th. The shares were sold at an average price of $362.92, for a total value of $90,730,000.00. Following the transaction, the director owned 2,457,331 shares of the company’s stock, valued at approximately $891,814,566.52. This trade represents a 9.23% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Company insiders own 5.20% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have recently commented on SYK shares. Citigroup restated a “market outperform” rating on shares of Stryker in a report on Friday, January 30th. Barclays reaffirmed an “overweight” rating and issued a $469.00 price target on shares of Stryker in a report on Monday, February 2nd. Truist Financial decreased their price objective on shares of Stryker from $400.00 to $392.00 and set a “hold” rating on the stock in a report on Thursday, December 18th. Piper Sandler restated an “overweight” rating on shares of Stryker in a research report on Tuesday, January 27th. Finally, The Goldman Sachs Group set a $399.00 target price on shares of Stryker in a research note on Friday, January 9th. Fourteen equities research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $427.50.

Stryker Stock Down 1.0%

NYSE SYK opened at $332.48 on Tuesday. The stock has a market capitalization of $127.24 billion, a P/E ratio of 39.58, a price-to-earnings-growth ratio of 1.96 and a beta of 0.85. Stryker Corporation has a 52 week low of $328.23 and a 52 week high of $404.87. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.21 and a current ratio of 1.89. The stock has a fifty day moving average of $362.68 and a 200-day moving average of $365.29.

Stryker (NYSE:SYK) last issued its quarterly earnings results on Thursday, January 29th. The medical technology company reported $4.47 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.40 by $0.07. The business had revenue of $7.17 billion for the quarter, compared to analyst estimates of $7.12 billion. Stryker had a return on equity of 24.41% and a net margin of 12.92%.The firm’s revenue for the quarter was up 11.4% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $4.01 earnings per share. On average, equities research analysts forecast that Stryker Corporation will post 13.47 EPS for the current year.

Stryker Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, April 30th. Shareholders of record on Tuesday, March 31st will be given a dividend of $0.88 per share. The ex-dividend date is Tuesday, March 31st. This represents a $3.52 dividend on an annualized basis and a yield of 1.1%. Stryker’s dividend payout ratio is presently 41.90%.

Stryker Company Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.